Artificial intelligence (AI) regulation and litigation are set to take center stage in 2026, as new laws, guidance, and enforcement priorities ...
Men's and women's fashion director David Thielebeule talks what's selling in men's footwear and how the retailer stays in ...
This comprehensive 2026 report on Gelatine Sculpt provides an in-depth examination of the Gelatine Sculpt supplement's ...
Palladium (PA00), platinum (PL00), uranium and other industrial and strategic metals were caught in the crossfire of last week's gold and silver liquidation. Their fundamentals did not suddenly ...
The Middle East projects market is seeing a surge in “brownfield”1 expansion projects where owners are seeking to refurbish or upgrade ...
Bringing children home from the al-Hol and al-Roj camps both upholds their rights and protects them and society from the ...
Fabrinet (NYSE:FN) Q2 2026 Earnings Call Transcript February 2, 2026 Fabrinet beats earnings expectations. Reported EPS is $3 ...
The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
Recently, the research team led by Professor Jun Pang from the Department of Urology at The Seventh Affiliated Hospital of Sun Yat-sen University ...
By Betsabe Botaitis, CFO at P2P.org Stablecoins have grown far beyond a niche trading instrument. With more than $300 billion ...
EducationDynamics just released its first report of the year with the 2026 Marketing and Enrollment Management Benchmarks: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results